Brooks Laboratories [BROOKS] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Brooks Laboratories
NSE
Loading...

Gujarat Themis
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Brooks Laboratories wins in 7 metrics, Gujarat Themis wins in 12 metrics, with 0 ties. Gujarat Themis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Brooks Laboratories | Gujarat Themis | Better |
---|---|---|---|
P/E Ratio (TTM) | 310.21 | 96.89 | Gujarat Themis |
Price-to-Book Ratio | 4.01 | 17.39 | Brooks Laboratories |
Debt-to-Equity Ratio | 7.73 | 12.27 | Brooks Laboratories |
PEG Ratio | 25.09 | -3.07 | Gujarat Themis |
EV/EBITDA | 55.91 | 65.59 | Brooks Laboratories |
Profit Margin (TTM) | 2.25% | 30.17% | Gujarat Themis |
Operating Margin (TTM) | 10.72% | 33.14% | Gujarat Themis |
EBITDA Margin (TTM) | 10.72% | 33.14% | Gujarat Themis |
Return on Equity | -10.16% | 19.64% | Gujarat Themis |
Return on Assets (TTM) | -8.06% | 16.19% | Gujarat Themis |
Free Cash Flow (TTM) | $15.98M | $-251.22M | Brooks Laboratories |
1-Year Return | 3.25% | 83.00% | Gujarat Themis |
Price-to-Sales Ratio (TTM) | 4.80 | 29.28 | Brooks Laboratories |
Enterprise Value | $4.37B | $42.26B | Gujarat Themis |
EV/Revenue Ratio | 4.85 | 28.58 | Brooks Laboratories |
Gross Profit Margin (TTM) | 32.19% | 77.71% | Gujarat Themis |
Revenue per Share (TTM) | $32 | $14 | Brooks Laboratories |
Earnings per Share (Diluted) | $0.47 | $4.09 | Gujarat Themis |
Beta (Stock Volatility) | 0.71 | -0.40 | Gujarat Themis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Brooks Laboratories vs Gujarat Themis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Brooks Laboratories | -1.25% | -3.85% | -10.63% | 7.01% | 20.53% | -21.44% |
Gujarat Themis | 1.09% | 10.88% | 7.56% | 26.97% | 64.54% | 64.54% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Brooks Laboratories | 3.25% | 16.03% | 270.10% | 141.57% | 310.87% | 310.87% |
Gujarat Themis | 83.00% | 83.00% | 83.00% | 83.00% | 83.00% | 83.00% |
Performance & Financial Health Analysis: Brooks Laboratories vs Gujarat Themis
Metric | BROOKS | GUJTHEM |
---|---|---|
Market Information | ||
Market Cap | ₹4.32B | ₹43.28B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 23,021 | 137,612 |
90 Day Avg. Volume | 20,473 | 213,338 |
Last Close | ₹144.34 | ₹400.60 |
52 Week Range | ₹95.55 - ₹198.86 | ₹208.00 - ₹405.00 |
% from 52W High | -27.42% | -1.09% |
All-Time High | ₹198.86 (Jan 06, 2025) | ₹405.00 (Aug 01, 2025) |
% from All-Time High | -27.42% | -1.09% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.42% | -0.08% |
Quarterly Earnings Growth | 0.35% | -0.32% |
Financial Health | ||
Profit Margin (TTM) | 0.02% | 0.30% |
Operating Margin (TTM) | 0.11% | 0.33% |
Return on Equity (TTM) | -0.10% | 0.20% |
Debt to Equity (MRQ) | 7.73 | 12.27 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹36.34 | ₹22.80 |
Cash per Share (MRQ) | ₹0.42 | ₹1.15 |
Operating Cash Flow (TTM) | ₹-42,666,000 | ₹969.95M |
Levered Free Cash Flow (TTM) | ₹-99,670,000 | ₹487.72M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Brooks Laboratories vs Gujarat Themis
Metric | BROOKS | GUJTHEM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 310.21 | 96.89 |
Forward P/E | 25.09 | N/A |
PEG Ratio | 25.09 | -3.07 |
Price to Sales (TTM) | 4.80 | 29.28 |
Price to Book (MRQ) | 4.01 | 17.39 |
Market Capitalization | ||
Market Capitalization | ₹4.32B | ₹43.28B |
Enterprise Value | ₹4.37B | ₹42.26B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.85 | 28.58 |
Enterprise to EBITDA | 55.91 | 65.59 |
Risk & Other Metrics | ||
Beta | 0.71 | -0.40 |
Book Value per Share (MRQ) | ₹36.34 | ₹22.80 |
Financial Statements Comparison: Brooks Laboratories vs Gujarat Themis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BROOKS | GUJTHEM |
---|---|---|
Revenue/Sales | ₹233.17M | ₹377.36M |
Cost of Goods Sold | ₹158.11M | ₹83.50M |
Gross Profit | ₹75.06M | ₹293.86M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹11.53M | ₹148.11M |
EBITDA | ₹-6.34M | ₹173.87M |
Pre-Tax Income | ₹-12.83M | ₹160.87M |
Income Tax | ₹1.75M | ₹40.89M |
Net Income (Profit) | ₹-14.58M | ₹119.98M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BROOKS | GUJTHEM |
---|---|---|
Cash & Equivalents | ₹434,000 | ₹116.94M |
Total Current Assets | ₹338.77M | ₹519.73M |
Total Current Liabilities | ₹228.44M | ₹205.60M |
Long-Term Debt | ₹13.70M | ₹296.36M |
Total Shareholders Equity | ₹981.04M | ₹2.48B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹139.72M | ₹411.30M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BROOKS | GUJTHEM |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | BROOKS | GUJTHEM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 23,021 | 137,612 |
Average Daily Volume (90 Day) | 20,473 | 213,338 |
Shares Outstanding | 29.46M | 108.97M |
Float Shares | 13.73M | 30.70M |
% Held by Insiders | 0.55% | 0.72% |
% Held by Institutions | 0.10% | 0.01% |
Dividend Analysis & Yield Comparison: Brooks Laboratories vs Gujarat Themis
Metric | BROOKS | GUJTHEM |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |